http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022305012-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
filingDate 2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2387e451b7679e9c393091804981fdbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa12507475c902dce6ed692fcf392c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5982faff1cd459de05d9cf8848bbc4a
publicationDate 2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022305012-A1
titleOfInvention Lemborexant for treating sleep issues
abstract Methods of improving subjective sleep efficiency, reducing subjective sleep onset latency, and/or reducing subjective wake after sleep onset in subjects comprising administering to the subject 5 mg or 10 mg of lemborexant or an equivalent dose of a pharmaceutically acceptable salt thereof are disclosed herein. Also disclosed herein is lemborexant or a pharmaceutically acceptable salt thereof for use in improving subjective sleep efficiency, reducing subjective sleep onset latency, and/or reducing subjective wake after sleep onset in a subject comprising administering to the subject 5 mg or 10 mg of lemborexant or an equivalent dose of a pharmaceutically acceptable salt thereof.
priorityDate 2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411473893
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO55232
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GLF6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5732
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3015207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67474038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449901282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416218147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO43612
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25723
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77668
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426341006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO55241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410916410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15171
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID607641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44377279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44404987
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56944144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24965990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16134267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426272319

Total number of triples: 49.